Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

NCT00423839 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00423839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
Lead sponsor
University of Oxford
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2003
Completion date
July 31, 2005
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis